Global Human DNA Vaccines Market Research Report 2023

Report ID: 1894217 | Published Date: Oct 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human DNA Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Recombinant Protein Vaccine
        1.2.3 Gene-Based Vaccine
    1.3 Market by Application
        1.3.1 Global Human DNA Vaccines Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Influenza
        1.3.3 Human Papillomavirus
        1.3.4 HIV
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Human DNA Vaccines Market Perspective (2017-2028)
    2.2 Human DNA Vaccines Growth Trends by Region
        2.2.1 Human DNA Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Human DNA Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 Human DNA Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 Human DNA Vaccines Market Dynamics
        2.3.1 Human DNA Vaccines Industry Trends
        2.3.2 Human DNA Vaccines Market Drivers
        2.3.3 Human DNA Vaccines Market Challenges
        2.3.4 Human DNA Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Human DNA Vaccines Players by Revenue
        3.1.1 Global Top Human DNA Vaccines Players by Revenue (2017-2022)
        3.1.2 Global Human DNA Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global Human DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Human DNA Vaccines Revenue
    3.4 Global Human DNA Vaccines Market Concentration Ratio
        3.4.1 Global Human DNA Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human DNA Vaccines Revenue in 2021
    3.5 Human DNA Vaccines Key Players Head office and Area Served
    3.6 Key Players Human DNA Vaccines Product Solution and Service
    3.7 Date of Enter into Human DNA Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Human DNA Vaccines Breakdown Data by Type
    4.1 Global Human DNA Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global Human DNA Vaccines Forecasted Market Size by Type (2023-2028)
5 Human DNA Vaccines Breakdown Data by Application
    5.1 Global Human DNA Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global Human DNA Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Human DNA Vaccines Market Size (2017-2028)
    6.2 North America Human DNA Vaccines Market Size by Country (2017-2022)
    6.3 North America Human DNA Vaccines Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Human DNA Vaccines Market Size (2017-2028)
    7.2 Europe Human DNA Vaccines Market Size by Country (2017-2022)
    7.3 Europe Human DNA Vaccines Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Human DNA Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific Human DNA Vaccines Market Size by Country (2017-2022)
    8.3 Asia-Pacific Human DNA Vaccines Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Human DNA Vaccines Market Size (2017-2028)
    9.2 Latin America Human DNA Vaccines Market Size by Country (2017-2022)
    9.3 Latin America Human DNA Vaccines Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Human DNA Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa Human DNA Vaccines Market Size by Country (2017-2022)
    10.3 Middle East & Africa Human DNA Vaccines Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Human DNA Vaccines Introduction
        11.1.4 Merck Revenue in Human DNA Vaccines Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 GSK
        11.2.1 GSK Company Detail
        11.2.2 GSK Business Overview
        11.2.3 GSK Human DNA Vaccines Introduction
        11.2.4 GSK Revenue in Human DNA Vaccines Business (2017-2022)
        11.2.5 GSK Recent Development
    11.3 Sanofi
        11.3.1 Sanofi Company Detail
        11.3.2 Sanofi Business Overview
        11.3.3 Sanofi Human DNA Vaccines Introduction
        11.3.4 Sanofi Revenue in Human DNA Vaccines Business (2017-2022)
        11.3.5 Sanofi Recent Development
    11.4 Zoties
        11.4.1 Zoties Company Detail
        11.4.2 Zoties Business Overview
        11.4.3 Zoties Human DNA Vaccines Introduction
        11.4.4 Zoties Revenue in Human DNA Vaccines Business (2017-2022)
        11.4.5 Zoties Recent Development
    11.5 Elanco
        11.5.1 Elanco Company Detail
        11.5.2 Elanco Business Overview
        11.5.3 Elanco Human DNA Vaccines Introduction
        11.5.4 Elanco Revenue in Human DNA Vaccines Business (2017-2022)
        11.5.5 Elanco Recent Development
    11.6 Boehringer-Ingelheim
        11.6.1 Boehringer-Ingelheim Company Detail
        11.6.2 Boehringer-Ingelheim Business Overview
        11.6.3 Boehringer-Ingelheim Human DNA Vaccines Introduction
        11.6.4 Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2017-2022)
        11.6.5 Boehringer-Ingelheim Recent Development
    11.7 Indian Immunologicals
        11.7.1 Indian Immunologicals Company Detail
        11.7.2 Indian Immunologicals Business Overview
        11.7.3 Indian Immunologicals Human DNA Vaccines Introduction
        11.7.4 Indian Immunologicals Revenue in Human DNA Vaccines Business (2017-2022)
        11.7.5 Indian Immunologicals Recent Development
    11.8 Plumbline Life Sciences
        11.8.1 Plumbline Life Sciences Company Detail
        11.8.2 Plumbline Life Sciences Business Overview
        11.8.3 Plumbline Life Sciences Human DNA Vaccines Introduction
        11.8.4 Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2017-2022)
        11.8.5 Plumbline Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Human DNA Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Recombinant Protein Vaccine
    Table 3. Key Players of Gene-Based Vaccine
    Table 4. Global Human DNA Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Human DNA Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Human DNA Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Human DNA Vaccines Market Share by Region (2017-2022)
    Table 8. Global Human DNA Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Human DNA Vaccines Market Share by Region (2023-2028)
    Table 10. Human DNA Vaccines Market Trends
    Table 11. Human DNA Vaccines Market Drivers
    Table 12. Human DNA Vaccines Market Challenges
    Table 13. Human DNA Vaccines Market Restraints
    Table 14. Global Human DNA Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Human DNA Vaccines Market Share by Players (2017-2022)
    Table 16. Global Top Human DNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2021)
    Table 17. Ranking of Global Top Human DNA Vaccines Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Human DNA Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Human DNA Vaccines Product Solution and Service
    Table 21. Date of Enter into Human DNA Vaccines Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Human DNA Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Human DNA Vaccines Revenue Market Share by Type (2017-2022)
    Table 25. Global Human DNA Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Human DNA Vaccines Revenue Market Share by Type (2023-2028)
    Table 27. Global Human DNA Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Human DNA Vaccines Revenue Market Share by Application (2017-2022)
    Table 29. Global Human DNA Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Human DNA Vaccines Revenue Market Share by Application (2023-2028)
    Table 31. North America Human DNA Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Human DNA Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Human DNA Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Human DNA Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Human DNA Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Human DNA Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Human DNA Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Human DNA Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Human DNA Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Human DNA Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Merck Company Detail
    Table 42. Merck Business Overview
    Table 43. Merck Human DNA Vaccines Product
    Table 44. Merck Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 45. Merck Recent Development
    Table 46. GSK Company Detail
    Table 47. GSK Business Overview
    Table 48. GSK Human DNA Vaccines Product
    Table 49. GSK Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 50. GSK Recent Development
    Table 51. Sanofi Company Detail
    Table 52. Sanofi Business Overview
    Table 53. Sanofi Human DNA Vaccines Product
    Table 54. Sanofi Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 55. Sanofi Recent Development
    Table 56. Zoties Company Detail
    Table 57. Zoties Business Overview
    Table 58. Zoties Human DNA Vaccines Product
    Table 59. Zoties Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 60. Zoties Recent Development
    Table 61. Elanco Company Detail
    Table 62. Elanco Business Overview
    Table 63. Elanco Human DNA Vaccines Product
    Table 64. Elanco Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 65. Elanco Recent Development
    Table 66. Boehringer-Ingelheim Company Detail
    Table 67. Boehringer-Ingelheim Business Overview
    Table 68. Boehringer-Ingelheim Human DNA Vaccines Product
    Table 69. Boehringer-Ingelheim Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 70. Boehringer-Ingelheim Recent Development
    Table 71. Indian Immunologicals Company Detail
    Table 72. Indian Immunologicals Business Overview
    Table 73. Indian Immunologicals Human DNA Vaccines Product
    Table 74. Indian Immunologicals Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 75. Indian Immunologicals Recent Development
    Table 76. Plumbline Life Sciences Company Detail
    Table 77. Plumbline Life Sciences Business Overview
    Table 78. Plumbline Life Sciences Human DNA Vaccines Product
    Table 79. Plumbline Life Sciences Revenue in Human DNA Vaccines Business (2017-2022) & (US$ Million)
    Table 80. Plumbline Life Sciences Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human DNA Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. Recombinant Protein Vaccine Features
    Figure 3. Gene-Based Vaccine Features
    Figure 4. Global Human DNA Vaccines Market Share by Application in 2021 & 2028
    Figure 5. Influenza Case Studies
    Figure 6. Human Papillomavirus Case Studies
    Figure 7. HIV Case Studies
    Figure 8. Human DNA Vaccines Report Years Considered
    Figure 9. Global Human DNA Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Human DNA Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human DNA Vaccines Market Share by Region: 2021 VS 2028
    Figure 12. Global Human DNA Vaccines Market Share by Players in 2021
    Figure 13. Global Top Human DNA Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human DNA Vaccines as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Human DNA Vaccines Revenue in 2021
    Figure 15. North America Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Human DNA Vaccines Market Share by Country (2017-2028)
    Figure 17. United States Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Human DNA Vaccines Market Share by Country (2017-2028)
    Figure 21. Germany Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Human DNA Vaccines Market Share by Region (2017-2028)
    Figure 29. China Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Human DNA Vaccines Market Share by Country (2017-2028)
    Figure 37. Mexico Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Human DNA Vaccines Market Share by Country (2017-2028)
    Figure 41. Turkey Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Human DNA Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Merck Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 44. GSK Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 45. Sanofi Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 46. Zoties Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 47. Elanco Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 48. Boehringer-Ingelheim Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 49. Indian Immunologicals Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 50. Plumbline Life Sciences Revenue Growth Rate in Human DNA Vaccines Business (2017-2022)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Frequently Asked Questions
Human DNA Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human DNA Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human DNA Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Oxo-octyl Acetate

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Hydro Stoves

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More